V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10221431 | 10055044 | 1.69 | 76 | Palliative (P) | 2020-01-27 | 2020-01-30 | CEMIPLIMAB | N | N | CEMIPLIMAB | 101024497 |
| 10221607 | 10055045 | 1.62 | 89.8 | null | 2019-02-08 | 2019-02-20 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100583888 |
| 10221782 | 10055047 | 1.75 | 76.2 | null | 2019-06-12 | 2019-06-18 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101823022 |
| 10223151 | 10055050 | 1.62 | 109.4 | Disease modification (D) | 2017-12-31 | 2018-01-28 | Avelumab | 02 | N | DARATUMUMAB | 101642991 |
| 10223264 | 10055051 | 1.53 | 79.5 | Palliative (P) | 2019-10-26 | 2019-11-26 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100082690 |
| 10223474 | 10055052 | 1.9 | 67.4 | Adjuvant (A) | null | 2021-05-04 | Venetoclax | 02 | N | VENETOCLAX | 101375855 |
| 10223520 | 10055053 | 1.8 | 87.6 | null | 2021-07-22 | 2021-09-02 | Avelumab | 02 | N | AVELUMAB | 101753241 |
| 10224190 | 10055057 | null | 112.9 | null | 2016-10-07 | 2016-10-18 | Avelumab | 02 | null | VENETOCLAX | 100117113 |
| 10224269 | 10055058 | 1.75 | 76 | Palliative (P) | 2018-02-07 | 2018-02-21 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100678522 |
| 10224644 | 10055061 | 1.53 | 71.7 | 03 | 2019-09-10 | 2019-10-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100351225 |
| 10224661 | 10055062 | 1.84 | 0 | Palliative (P) | 2016-06-18 | 2018-05-16 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101263357 |
| 10224732 | 10055063 | null | 75.8 | null | null | 2019-01-05 | RUXOLITINIB | 2 | null | RUXOLITINIB | 101505407 |
| 10224763 | 10055064 | 0 | 101.3 | Adjuvant (A) | 2017-12-17 | 2017-12-26 | RUXOLITINIB | N | N | RUXOLITINIB | 100620876 |
| 10224890 | 10055065 | 1.68 | 74.6 | null | 2019-05-20 | 2021-09-01 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101393141 |
| 10225460 | 10055066 | 1.72 | 76 | Palliative (P) | 2021-06-15 | 2021-07-07 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101828012 |
| 10225485 | 10055067 | 1.62 | 77 | null | 2022-05-01 | 2022-05-03 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100885629 |
| 10225753 | 10055069 | 1.63 | 56.6 | Neo-adjuvant (N) | 2018-12-29 | 2018-12-29 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101862080 |
| 10225838 | 10055071 | 1.72 | 73 | 03 | 2021-10-21 | 2022-01-28 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101152325 |
| 10226421 | 10055075 | 1.62 | 75.7 | Palliative (P) | 2016-06-01 | 2017-05-07 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100456390 |
| 10226635 | 10055076 | 1.62 | 83.8 | Palliative (P) | 2021-05-22 | 2021-05-28 | CEMIPLIMAB | null | N | CEMIPLIMAB | 101668852 |
| 10226763 | 10055077 | 1.65 | 76.9 | null | 2021-11-08 | 2021-11-08 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101141825 |
| 10226863 | 10055078 | 0 | 71 | null | 2019-05-12 | 2019-06-25 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101573223 |
| 10227001 | 10055079 | 1.81 | 100.8 | null | 2019-10-16 | 2019-11-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100796805 |
| 10227046 | 10055080 | 0 | 71.8 | Palliative (P) | 2018-04-01 | 2018-06-11 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100523750 |
| 10227398 | 10055082 | 1.76 | 126.7 | Neo-adjuvant (N) | 2018-03-09 | 2018-06-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100126399 |
| 10227651 | 10055083 | 1.68 | 54.8 | null | 2018-06-17 | 2018-11-25 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101690601 |
| 10227760 | 10055084 | 1.67 | null | null | 2019-11-24 | 2019-12-02 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100629031 |
| 10229076 | 10055090 | 1.55 | 68.8 | Palliative (P) | 2021-11-19 | 2021-11-24 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 101801010 |
| 10229260 | 10055092 | 1.73 | 95.8 | null | 2020-01-11 | 2020-01-11 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101378180 |
| 10230452 | 10055095 | 1.58 | 77.4 | null | 2019-09-20 | 2019-10-12 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100288971 |
| 10230784 | 10055097 | 1.71 | 89.7 | null | 2020-09-14 | 2020-09-20 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101146406 |
| 10231140 | 10055100 | 1.6 | 59 | null | 2018-08-07 | 2018-08-21 | Avelumab | 02 | null | DARATUMUMAB | 101053845 |
| 10231281 | 10055101 | 1.72 | 85.1 | Adjuvant (A) | 2017-10-06 | 2017-11-02 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 100482473 |
| 10231374 | 10055102 | 1.63 | 0 | Neo-adjuvant (N) | 2020-11-18 | 2020-11-21 | CEMIPLIMAB | 02 | N | TRASTUZUMAB | 101483888 |
| 10231376 | 10055103 | 1.76 | 65 | null | 2018-10-21 | 2019-08-06 | Venetoclax | 02 | null | VENETOCLAX | 100676160 |
| 10231545 | 10055104 | 1.62 | 80 | Palliative (P) | 2019-06-17 | 2019-06-17 | Avelumab | 02 | N | TRASTUZUMAB | 101284356 |
| 10232064 | 10055105 | 1.52 | 73.5 | 03 | 2019-04-19 | 2019-04-19 | CEMIPLIMAB | N | N | CEMIPLIMAB | 101865721 |
| 10232178 | 10055106 | 1.86 | 69 | Palliative (P) | 2018-04-07 | 2018-04-07 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101522131 |
| 10232184 | 10055107 | 1.66 | 49.8 | null | 2019-12-22 | 2020-03-01 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 101559002 |
| 10232516 | 10055108 | 1.65 | 89.6 | Palliative (P) | 2018-06-07 | 2018-06-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 100853812 |
| 10233194 | 10055113 | 1.72 | 54.5 | null | 2019-03-18 | 2019-03-21 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 100233809 |
| 10233331 | 10055114 | 1.65 | 90 | Palliative (P) | 2020-10-08 | 2020-10-16 | Irinotecan + Modified De Gramont | 02 | N | BENDAMUSTINE + RITUXIMAB | 100238921 |
| 10233458 | 10055115 | 1.77 | 40.8 | null | 2019-02-06 | 2019-02-27 | RUXOLITINIB | null | null | RUXOLITINIB | 100974719 |
| 10233520 | 10055116 | 1.49 | 93.3 | null | 2020-11-20 | 2022-04-30 | Avelumab | 02 | null | AVELUMAB | 101031539 |
| 10233680 | 10055117 | 1.73 | 79 | null | 2018-09-10 | 2019-08-04 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100366842 |
| 10233683 | 10055118 | 1.59 | 66.3 | Palliative (P) | 2019-11-26 | 2019-12-10 | Avelumab | 02 | N | CARBOPLATIN + GEMCITABINE | 101776265 |
| 10233986 | 10055119 | 1.67 | 91.6 | Adjuvant (A) | 2018-10-31 | 2018-11-13 | NIVOLUMAB | N | N | CAPECITABINE + OXALIPLATIN | 101462192 |
| 10234350 | 10055121 | 1.58 | 100.6 | null | 2019-02-24 | 2019-02-28 | CEMIPLIMAB | N | null | CEMIPLIMAB | 100252726 |
| 10234437 | 10055122 | 1.79 | null | 03 | 2019-10-27 | 2019-10-27 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100621653 |
| 10234530 | 10055123 | 1.64 | 54.7 | null | 2021-10-29 | 2021-12-25 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101023388 |